tradingkey.logo

Caris Life Sciences Inc

CAI
22.320USD
+0.320+1.45%
交易中 美东报价延迟15分钟
6.20B总市值
亏损市盈率 TTM

Caris Life Sciences Inc

22.320
+0.320+1.45%

关于 Caris Life Sciences Inc 公司

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Caris Life Sciences Inc简介

公司代码CAI
公司名称Caris Life Sciences Inc
上市日期Jun 18, 2025
CEOHalbert (David Dean)
员工数量- -
证券类型Ordinary Share
年结日Jun 18
公司地址750 W. John Carpenter Freeway
城市IRVING
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编75039
电话18667718946
网址https://www.carislifesciences.com/
公司代码CAI
上市日期Jun 18, 2025
CEOHalbert (David Dean)

Caris Life Sciences Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-14517.00%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
+16129.00%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Dr. Jonathan Knowles, Ph.D.
Dr. Jonathan Knowles, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
213.55M
98.49%
International
3.28M
1.51%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 1月31日 周六
更新时间: 1月31日 周六
持股股东
股东类型
持股股东
持股股东
占比
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
其他
33.40%
持股股东
持股股东
占比
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
其他
33.40%
股东类型
持股股东
占比
Individual Investor
48.48%
Investment Advisor
21.18%
Hedge Fund
11.06%
Private Equity
10.54%
Investment Advisor/Hedge Fund
5.08%
Pension Fund
0.53%
Research Firm
0.29%
Sovereign Wealth Fund
0.13%
Family Office
0.02%
其他
2.70%

机构持股

更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
228
134.49M
38.87%
--
2025Q4
261
137.01M
48.56%
+26.69M
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Halbert (David D)
122.76M
43.51%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.64%
--
--
Sep 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.18%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.68%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.59%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
9.58M
3.39%
+963.04K
+11.18%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
8.03M
2.84%
+721.77K
+9.88%
Sep 30, 2025
Braidwell LP
7.32M
2.59%
--
--
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.92M
2.45%
+154.50K
+2.29%
Sep 30, 2025
Silver Lake Partners
5.29M
1.88%
--
--
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
查看更多
ARK Genomic Revolution ETF
占比0.67%
Texas Capital Texas Small Cap Equity Index ETF
占比0.52%
Renaissance IPO ETF
占比0.43%
RiverNorth Patriot ETF
占比0.3%
Franklin Genomic Advancements ETF
占比0.29%
Invesco Russell 1000 Equal Weight ETF
占比0.08%
Inspire 500 ETF
占比0.07%
T Rowe Price Small-Mid Cap ETF
占比0.05%
Texas Capital Texas Equity Index ETF
占比0.04%
Fidelity Nasdaq Composite Index ETF
占比0.02%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI